1. Home
  2. Live Updates
  3. Roche low code enablement application platform

Page 58 - Roche Low Code Enablement Application Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche low code enablement application platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Low Code Enablement Application Platform Today - Breaking & Trending Today

Roche to showcase the future of diagnostic solutions at EuroMedLab, 10 to 14 April 2022 Munich at ICM International Congress Center

New diagnostics solutions will be presented that help clinicians improve patient care and support healthcare systems. Participants can join virtually or onsite. ....

Switzerland General , United States , Moritz Hartmann , Ann Costello , Elizabeth Baxter , Roche Euromedlab , Jonathan Parry , European Congress , Laboratory Medicines Euromedlab , Roche Diagnostics Solutions , Roche Diagnostics Communications , Roche Group , Global Head Of Roche Information Solutions , Tissue Comprehensive Genomic Profiling Kit , Roche Diagnostics , Clinical Chemistry , Laboratory Medicines , Tissue Comprehensive Genomic Profiling , Global Head , Roche Information , Dow Jones Sustainability Indices , Chugai Pharmaceutical ,

Roche gets USFDA priority review for Actemra to treat Covid-19

Basel: Roche today announced that the U.S. Food and Drug Administration (USFDA) has accepted the company s supplemental Biologics License Application (sBLA) and has granted Priority Review for. ....

United States , Hong Kong , United Kingdom , Levi Garraway , Actemra Roactemra , Tools Accelerator Initiative , European Union , World Health Organization , Head Of Global Product Development , Chief Medical Officer , Global Product Development , Emergency Use Authorization , World Health , Roche News , Covid 19 ,

Roche's lung cancer gamble flames out as TIGIT digits come up short in phase 3

Roche’s gamble on anti-TIGIT drug tiragolumab in small cell lung cancer (SCLC) has flamed out. ....

Small Cell Lung Cancer , Failed Trials , Checkpoint Inhibitors , Clinical Data , Fierce Biotech Homepage ,

Roche: Phase III SKYSCRAPER-02 Study In ES-SCLC Fails To Meet Co-primary Endpoint

SOUTH SAN FRANCISCO (dpa-AFX) - Swiss drug major Roche Holding AG (RHHBY) announced Wednesday that the phase III SKYSCRAPER-02 study in extensive-stage small cell lung cancer or ES-SCLC did not ....

Drug Administration , Roche Holding , Breakthrough Therapy Designation ,

Brokerages Set Roche Holding AG (OTCMKTS:RHHBY) Price Target at $158.14

Shares of Roche Holding AG (OTCMKTS:RHHBY – Get Rating) have been assigned an average rating of “Buy” from the twelve ratings firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation […] ....

Stifel Nicolaus , Zacks Investment Research , First Horizon Advisors Inc , Abbrea Capital , Scout Investments Inc , Jpmorgan Chase Co , Thomas White International Ltd , Dearborn Partners , Roche Holding , Get Rating , Investment Research , Horizon Advisors , White International , Scout Investments , Otcmkts Rhhby ,